{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:20:26Z","timestamp":1788495626798,"version":"build-2803163510"},"reference-count":63,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00345","type":"journal-article","created":{"date-parts":[[2016,9,28]],"date-time":"2016-09-28T04:02:25Z","timestamp":1475035345000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":69,"title":["Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor"],"prefix":"10.3389","volume":"7","author":[{"given":"Ming","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Ming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ptr.3207","article-title":"Milk thistle in liver diseases: past, present, future.","volume":"24","author":"Abenavoli","year":"2010","journal-title":"Phytother. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.5897\/jmpr09.472","article-title":"A review of natural products with hepatoprotective activity.","volume":"4","author":"Adewusi","year":"2010","journal-title":"J. Med. Plants Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1053\/jhep.2000.18663","article-title":"Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.","volume":"32","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/clpt.2010.2","article-title":"Nuclear receptors, inflammation, and liver disease: insights for cholestatic and fatty liver diseases.","volume":"87","author":"Arrese","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmet","article-title":"NF-\u03baB, inflammation, and metabolic disease.","volume":"13","author":"Baker","year":"2011","journal-title":"Cell Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond.","volume":"62","author":"Beuers","year":"2015","journal-title":"J. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1039\/c3np70122k","article-title":"Chemistry of silybin.","volume":"31","author":"Biedermann","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/07853890500401234","article-title":"The metabolic syndrome and cardiovascular disease.","volume":"38","author":"Bonora","year":"2006","journal-title":"Ann. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1211\/0022357021778637","article-title":"Natural products as targeted modulators of the nuclear factor- K B pathway.","volume":"54","author":"Bremner","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"11039","DOI":"10.1074\/jbc.m510258200","article-title":"The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.","volume":"281","author":"Cariou","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"853501","key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/853501","article-title":"TGR5: a novel target for weight maintenance and glucose metabolism.","volume":"2011","author":"Chen","year":"2011","journal-title":"Exp. Diabetes Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1194\/jlr.M001602","article-title":"FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa\/fa) obese rats.","volume":"51","author":"Cipriani","year":"2010","journal-title":"J. Lipid Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1258\/000456303322326407","article-title":"Herbal remedies and clinical biochemistry.","volume":"40","author":"Corns","year":"2003","journal-title":"Ann. Clin. Biochem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/sj.onc.1205240","article-title":"Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.","volume":"21","author":"Dhanalakshmi","year":"2002","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/bmj.f1936","article-title":"Orlistat and the risk of acute liver injury: self controlled case series study in UK Clinical Practice Research Datalink.","volume":"346","author":"Douglas","year":"2013","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/hep.21802","article-title":"Nuclear factor-\u03baB and the hepatic inflammation-fibrosis- cancer axis.","volume":"46","author":"Elsharkawy","year":"2007","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u22c51 million participants.","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipids from animal tissues.","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.233304","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin\u2013new and emerging applications in medicine.","volume":"14","author":"Gaz\u00e1k","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling.","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2125.2009.03549.x","article-title":"Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.","volume":"68","author":"Heal","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20787","article-title":"Milk thistle and chronic liver disease.","volume":"42","author":"Hoofnagle","year":"2005","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbrc.2006.07.095","article-title":"Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway.","volume":"348","author":"Huang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1900\/RDS.2014.11.167","article-title":"The therapeutic potential of milk thistle in diabetes.","volume":"11","author":"Kazazis","year":"2014","journal-title":"Rev. Diabet. Stud."},{"key":"B26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.clinre.2012.03.008","article-title":"Perspective: TGR5 (Gpbar-1) in liver physiology and disease.","volume":"36","author":"Keitel","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"B27","first-page":"193","article-title":"A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos\u00ae).","volume":"10","author":"Kidd","year":"2005","journal-title":"Altern. Med. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1194\/jlr.m700330-jlr200","article-title":"Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.","volume":"48","author":"Kim","year":"2007","journal-title":"J. Lipid Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1039\/b300099k","article-title":"Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum).","volume":"1","author":"Kim","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1124\/jpet.108.144600","article-title":"Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.","volume":"328","author":"Kong","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0021-9673(02)01971-4","article-title":"Analysis of the active components of silymarin.","volume":"990","author":"Kvasni\u010dka","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1021\/np030163b","article-title":"Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle).","volume":"66","author":"Lee","year":"2003","journal-title":"J. Nat. Prod."},{"key":"B33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor.","volume":"31","author":"Lee","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jhep.2014.01.001","article-title":"Failing FXR expression in the liver links aging to hepatic steatosis.","volume":"60","author":"Lefebvre","year":"2014","journal-title":"J. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/jci18945","article-title":"Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.","volume":"112","author":"Liu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.freeradbiomed.2012.02.008","article-title":"Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial.","volume":"52","author":"Loguercio","year":"2012","journal-title":"Free. Radic. Biol. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3748\/wjg.v17.i18.2288","article-title":"Silybin and the liver: from basic research to clinical practice.","volume":"17","author":"Loguercio","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids.","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0168-8278(10)60004-9","article-title":"Farnesoid-x receptor agonists: a new class of for the treatment of pbc? an international study evaluating the addition of int-747 to ursodeoxycholic acid.","volume":"52","author":"Mason","year":"2010","journal-title":"J. Hepatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system.","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"B41","first-page":"1073","article-title":"Silymarin attenuated hepatic steatosis through regulation of lipid metabolism and oxidative stress in a mouse model of nonalcoholic fatty liver disease (NAFLD).","volume":"8","author":"Ni","year":"2016","journal-title":"Am. J. Trans. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.26179","article-title":"Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection.","volume":"57","author":"Polyak","year":"2013","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2337\/db11-0030","article-title":"Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity.","volume":"60","author":"Prawitt","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/mc.21843","article-title":"Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-\u03baB signaling.","volume":"52","author":"Raina","year":"2013","journal-title":"Mol. Carcinog."},{"key":"B45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver.","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.trsl.2011.12.003","article-title":"Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.","volume":"159","author":"Salamone","year":"2012","journal-title":"Transl. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of silymarin in the treatment of liver diseases.","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/liv.12975","article-title":"Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.","volume":"36","author":"Salomone","year":"2016","journal-title":"Liver Int."},{"key":"B49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00011-014-0780-y","article-title":"Role of farnesoid X receptor in inflammation and resolution.","volume":"64","author":"Shaik","year":"2015","journal-title":"Inflamm. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis.","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"B51","first-page":"1102","article-title":"Antifibrotic properties of botanicals in chronic liver disease.","volume":"49","author":"Stickel","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/1534735407301942","article-title":"Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).","volume":"6","author":"Tamayo","year":"2007","journal-title":"Integr. Cancer Ther."},{"key":"B53","first-page":"42","article-title":"Trends in use of complementary and alternative medicine by US adults: 1997\u20132002.","volume":"11","author":"Tindle","year":"2005","journal-title":"Altern. Ther. Health Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0168-8278(97)80255-3","article-title":"Long-term (23 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients.","volume":"26","author":"Velussi","year":"1997","journal-title":"J. Hepatol."},{"issue":"5147468","key":"B55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5147468","article-title":"Silymarin in Type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.","volume":"2016","author":"Voroneanu","year":"2016","journal-title":"J. Diabetes Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1016\/j.ridd.2011.05.030","article-title":"Metabolic syndrome in children with and without developmental coordination disorder.","volume":"32","author":"Wahi","year":"2011","journal-title":"Res. Dev. Disabil."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor \u03baB in hepatic inflammatory response.","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2174\/1389557054553802","article-title":"FXR, a therapeutic target for bile acid and lipid disorders.","volume":"5","author":"Westin","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1089\/ars.2010.3134","article-title":"Silymarin: a novel antioxidant with antiglycation and antiinflammatory properties in vitro and in vivo.","volume":"14","author":"Wu","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"B60","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1158\/0008-5472.CAN-06-1078","article-title":"Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor.","volume":"67","author":"Yang","year":"2007","journal-title":"Cancer Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jep.2012.09.049","article-title":"Evaluation of the protective effect of Rhei Radix et Rhizoma against \u03b1-naphthylisothiocyanate induced liver injury based on metabolic profile of bile acids.","volume":"144","author":"Yang","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/hep.25905","article-title":"Promotion of liver regeneration\/repair by farnesoid X receptor in both liver and intestine in mice.","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T08:46:02Z","timestamp":1657356362000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00345\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,28]]},"references-count":63,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00345","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,28]]}}}